Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

被引：0
|
作者：
Godfrey, James [1 ]
Querfeld, Christiane [1 ]
Song, Joo [1 ]
Hamilton, Mark P. [2 ]
Miklos, David B. [2 ]
Alizadeh, Ash A. [2 ]
机构：
[1] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA
[2] Stanford Univ, Sch Med, Stanford, CA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：869 / 871
页数：3
相关论文
共 50 条
  • [31] Second Primary Malignancies after CAR T-Cell Therapy: A Systemic Review
    Shahzad, Moazzam
    Qasim, Hana
    Ponvilawan, Ben
    Amin, Muhammad Kashif
    Zulfiqar, Fizza
    Ismail, Areeba
    Ishaq, Muhammad Uzair
    Irfan, Sohaib
    Vyas, Abhinav
    Khamees, Ibrahim
    Ihsan, Rida
    Chaudhary, Sibgha Gull
    Anwar, Iqra
    Ahmed, Nausheen
    Shune, Leyla O.
    Abdallah, Al-Ola
    Mcguirk, Joseph P.
    Mushtaq, Muhammad Umair
    BLOOD, 2024, 144 : 7237 - 7238
  • [32] Recent advances in CAR T-cell therapy for lymphoma in China
    Che, Yuxuan
    Sun, Xiuhua
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (10): : 2793 - 2800
  • [33] CAR T-cell Therapy for Central Nervous System Lymphoma
    Houillier, Caroline
    Choquet, Sylvain
    CURRENT ONCOLOGY REPORTS, 2024, 26 (11) : 1521 - 1529
  • [34] Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma
    Frigault, Matthew J.
    Dietrich, Jorg
    Martinez-Lage, Maria
    Leick, Mark
    Choi, Bryan D.
    DeFilipp, Zachariah
    Chen, Yi-Bin
    Abramson, Jeremy
    Crombie, Jennifer
    Armand, Philippe
    Nayak, Lakshmi
    Panzini, Chris
    Riley, Lauren S.
    Gallagher, Kathleen
    Maus, Marcela V.
    BLOOD, 2019, 134 (11) : 860 - 866
  • [35] The Evolving Use of CAR T-Cell Therapy in Follicular Lymphoma
    Nastoupil, Loretta J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 684 - 686
  • [36] CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Retrospective Study
    Zhao, Liping
    Zhou, Qi
    Chen, Chen
    Ling, Zhuojun
    Wang, Kai
    Wu, Fan
    Xu, Jinlong
    Duan, Jiajia
    Wang, Zelin
    Wang, Quangang
    Pan, Jing
    BLOOD, 2023, 142
  • [37] Recent advances in CAR T-cell therapy for lymphoma in China
    Yuxuan Che
    Xiuhua Sun
    Clinical and Translational Oncology, 2023, 25 : 2793 - 2800
  • [38] CAR T-cell therapies: risk of secondary malignancy of T-cell origin
    Reactions Weekly, 2024, 2019 (1) : 1 - 1
  • [39] EXAMINING CAR T-CELL PATIENT AND CAREGIVER LONGER-TERM OUTCOMES AFTER CAR T-CELL THERAPY
    Andersen, Lucy
    Garfall, Alfred
    Porter, David
    Meghani, Salimah H.
    Deng, Jie
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
  • [40] CAR-T Cell Therapy for T-Cell Malignancies
    Testa, Ugo
    Chiusolo, Patrizia
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
12345